From cord to caudate: Characterizing umbilical cord blood stem cells and their paracrine interactions with the injured brain (Q48032820)

7 February 2018

title

From cord to caudate: Characterizing umbilical cord blood stem cells and their paracrine interactions with the injured brain (English)

1 reference

7 February 2018

Eric S Peeples

5

0 references

author name string

Priya F Maillacheruvu

1

1 reference

7 February 2018

Lauren M Engel

2

1 reference

7 February 2018

Isaiah T Crum

3

1 reference

7 February 2018

Devendra K Agrawal

4

1 reference

7 February 2018

language of work or name

English

0 references

publication date

5 October 2017

1 reference

7 February 2018

published in

Pediatric Research

1 reference

7 February 2018

Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Stem Cells for Neonatal Brain Disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Involvement of Immune Responses in the Efficacy of Cord Blood Cell Therapy for Cerebral Palsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Comparative growth behaviour and characterization of stem cells from human Wharton's jelly

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Isolation and characterization of mesenchymal cells from human fetal membranes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Umbilical cord blood-derived mesenchymal stem cells consist of a unique population of progenitors co-expressing mesenchymal stem cell and neuronal markers capable of instantaneous neuronal differentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Multipotent Stem Cells from Umbilical Cord: Cord Is Richer than Blood!

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Factor predicting total nucleated cell counts in cord blood units

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Delayed clamping of the umbilical cord after delivery and implications for public cord blood banking

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

High quality cord blood banking is feasible with delayed clamping practices. The eight-year experience and current status of the national Swedish Cord Blood Bank

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Enhancing endogenous stem cells in the newborn via delayed umbilical cord clamping

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Committee Opinion No. 684: Delayed Umbilical Cord Clamping After Birth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Umbilical Cord Milking Versus Delayed Cord Clamping in Preterm Infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Milking compared with delayed cord clamping to increase placental transfusion in preterm neonates: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Hypoxia-induced therapeutic neovascularization in a mouse model of an ischemic limb using cell aggregates composed of HUVECs and cbMSCs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Moderate Hypoxia Exhibits Increased Endothelial Progenitor Vessel-forming Ability However Gestational Diabetes Caused to Impede Compensatory Defense Reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Decreased level of cord blood circulating endothelial colony-forming cells in preeclampsia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Effects of preeclampsia on the yield of hematopoietic stem cells obtained from umbilical cord blood at delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Factors predicting the hematopoietic stem cells content of the umbilical cord blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Bigger is better: maternal and neonatal predictors of hematopoietic potential of umbilical cord blood units

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

A prenatal prediction model for total nucleated cell count increases the efficacy of umbilical cord blood banking

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Obstetric predictors of placental/umbilical cord blood volume for transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Analysis of maternal and neonatal factors that influence the nucleated and CD34+ cell yield for cord blood banking

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Predictors of high-quality cord blood units.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Cord blood hematopoietic progenitor cell concentration and infant sex.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Neonatal sex and weight influence CD34(+) cell concentration in umbilical cord blood but not stromal cell-derived factor 1-3'A polymorphism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Factors affecting banking quality of umbilical cord blood for transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Optimizing umbilical cord blood collection: impact of obstetric factors versus quality of cord blood units.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Cesarean section due to fetal distress increases the number of stem cells in umbilical cord blood

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Ischemic rat brain extracts induce human marrow stromal cell growth factor production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

IFATS collection: The conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Mesenchymal stem cells enhanced cardiac nerve sprouting via nerve growth factor in a rat model of myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Nerve growth factor protects the neonatal brain against hypoxic-ischemic injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic-ischemic brain injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain: effect of exogenous IGF-1 and GDNF.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Insulin-like growth factor-1 is an endogenous mediator of focal ischemia-induced neural progenitor proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

IGF-1 protects oligodendrocyte progenitor cells and improves neurological functions following cerebral hypoxia-ischemia in the neonatal rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Results of the Cord Blood Transplantation Study (COBLT): Outcomes of Unrelated Donor Umbilical Cord Blood Transplantation in Pediatric Patients with Lysosomal and Peroxisomal Storage Diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Repeated autologous umbilical cord blood infusions are feasible and had no acute safety issues in young babies with congenital hydrocephalus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Human allogeneic AB0/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Safety of Allogeneic Umbilical Cord Blood Stem Cells Therapy in Patients with Severe Cerebral Palsy: A Retrospective Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Effect of umbilical cord mesenchymal stromal cells on motor functions of identical twins with cerebral palsy: pilot study on the correlation of efficacy and hereditary factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Treatment of Cerebral Palsy with Stem Cells: A Report of 17 Cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Intravenous versus intrastriatal cord blood administration in a rodent model of stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Mesenchymal stem cells prevent hydrocephalus after severe intraventricular hemorrhage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Transplantation of human placenta-derived multipotent stem cells reduces ischemic brain injury in adult rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Amelioration of Ischemic Brain Injury in Rats With Human Umbilical Cord Blood Stem Cells: Mechanisms of Action.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Intranasal mesenchymal stem cell treatment for neonatal brain damage: long-term cognitive and sensorimotor improvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Intranasal administration of human MSC for ischemic brain injury in the mouse: in vitro and in vivo neuroregenerative functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Neuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2017.251

Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury

31 March 2020

1 reference

12 December 2020

Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood

1 reference

12 December 2020

Delayed Umbilical Cord Blood Clamping: First Line of Defense Against Neonatal and Age-Related Disorders

1 reference

12 December 2020

First Autologous Cord Blood Therapy for Pediatric Ischemic Stroke and Cerebral Palsy Caused by Cephalic Molding during Birth: Individual Treatment with Mononuclear Cells.

1 reference

12 December 2020

Mankind's first natural stem cell transplant.

1 reference

12 December 2020

Umbilical cord mesenchymal stem cells in neurological disorders: A clinical study.

1 reference

12 December 2020

Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality

1 reference

12 December 2020

Fetal exposure to a diabetic intrauterine environment resulted in a failure of cord blood endothelial progenitor cell adaptation against chronic hypoxia

1 reference

12 December 2020

Identifiers

DOI

10.1038/PR.2017.251

1 reference

7 February 2018

1 reference

7 February 2018